Nama Insights

Danaher Corporation (DHR)

Healthcare · Diagnostics Research · NYSE

S&P 500
Danaher Corporation (DHR) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $143.94B, a trailing price-to-earnings ratio of 25.2 and a free-cash-flow yield of 3.6%. Over the most recent reported fiscal year, revenue grew 2.9% and free cash flow per share grew 2.2%.
Market cap$143.94B
Trailing P/E25.2
FCF yield3.6%
Revenue growth (YoY)+2.9%
EPS growth (YoY)+4.1%
FCF/share growth (YoY)+2.2%
ExchangeNYSE
SectorHealthcare
IndustryDiagnostics Research
Explore live DHR data on Nama Insights →

Recent Congressional trades

Danaher Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Julie Johnson House Sell $1,001 - $15,000 Jan 5, 2026
Lisa McClain House Sell $1,001 - $15,000 Oct 1, 2025
Julia Letlow House Buy $1,001 - $15,000 Aug 11, 2025
Jefferson Shreve House Buy $15,001 - $50,000 May 15, 2025
Jefferson Shreve House Sell $15,001 - $50,000 Apr 25, 2025
Rob Bresnahan House Buy $15,001 - $50,000 Apr 8, 2025
John Curtis House Sell $1,001 - $15,000 Dec 4, 2023
Greg Stanton House Buy $1,001 - $15,000 Oct 21, 2023
Thomas H. Kean House Buy $1,001 - $15,000 Sep 14, 2023
Zoe Lofgren House Sell $1,001 - $15,000 Jun 6, 2023
Cindy Axne House Buy $1,001 - $15,000 Nov 24, 2022
Lois Frankel House Sell $1,001 - $15,000 Oct 21, 2022